Skip to main content

Table 1 Baseline characteristics of included patients with and without LAT/LASEC

From: Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation

  Total
(n = 472)
LAT /LASEC
group (n = 80)
Non-LAT/LASEC group (n = 392) P value
Clinical characteristics
 Age(yrs) 66.1 ± 10.8 70.2 ± 9.6 65.3 ± 10.8 < 0.001*
 Male (n, %) 271 (57.4%) 40 (50.0%) 231(58.9%) 0.154
 HR 86.5 ± 21.8 86.8 ± 18.9 86.4 ± 22.3 0.895
 SBP 134.1 ± 18.8 137.0 ± 21.7 133.4 ± 18.1 0.136
 DBP 78.7 ± 11.7 79.3 ± 13.1 78.6 ± 11.3 0.642
 Persistent AF (n, %) 154 (32.6%) 44 (55.0%) 107 (27.3%) < 0.001*
 Duration of symptoms (months) 45.0 ± 70.4 56.6 ± 76.1 42.4 ± 69.0 0.131
 Congestive heart failure (n, %) 73 (15.5%) 24 (30%) 49 (12.5%) 0.003*
 Hypertension (n, %) 277 (58.7%) 63 (78.8%) 214 (54.6%) < 0.001*
 Diabetes mellitus (n, %) 77 (16.3%) 20 (25.0%) 57 (14.5%) 0.065
 Previous stroke (n, %) 119 (25.2%) 26 (32.5%) 93 (23.7%) 0.174
 Vascular disease (n, %) 133 (28.2%) 32 (40.0%) 101 (25.8%) 0.045*
 CHA2DS2-VASc score 2.86 ± 1.81 3.79 ± 1.75 2.65 ± 1.76 < 0.001*
Antiplatelet and Anticoagulant drugs
 Aspirin 142 (30.1%) 15 (18.8%) 127 (32.4%) 0.033*
 Warfarin 187 (39.6%) 37 (46.3%) 150 (38.3%)
 Dabigatran 47 (10.0%) 13 (32.5%) 34 (8.7%)
 Rivaroxaban 2 (0.42%) 0 2 (0.51%)
  1. Values are mean ± standard deviation, or number (%)
  2. LAT left atrial thrombus, LASEC left atrial appendage spontaneous echo contrast, AF atrial fibrillation, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure. *P < 0.05